apilimod s6414 Search Results


apilimod  (Selleck Chemicals)
93
Selleck Chemicals apilimod
List of approved drugs used for in silico screening and their targets in the network model.
Apilimod, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/apilimod/product/Selleck Chemicals
Average 93 stars, based on 1 article reviews
apilimod - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
apilimod s6414  (Euromedex)
90
Euromedex apilimod s6414
List of approved drugs used for in silico screening and their targets in the network model.
Apilimod S6414, supplied by Euromedex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/apilimod s6414/product/Euromedex
Average 90 stars, based on 1 article reviews
apilimod s6414 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


List of approved drugs used for in silico screening and their targets in the network model.

Journal: NPJ Digital Medicine

Article Title: Executable network of SARS-CoV-2-host interaction predicts drug combination treatments

doi: 10.1038/s41746-022-00561-5

Figure Lengend Snippet: List of approved drugs used for in silico screening and their targets in the network model.

Article Snippet: Caco-2 cells were pre-treated with Camostat Mesilate (ApexBio, B2082), Apilimod (Selleckchem, S6414), Miltefosine (Cayman Chemicals, 63280), Dexamethasone (EMD Millipore, 265005) or DMSO (Sigma) vehicle control at 2x the final concentration for 2 h prior to infection in 50 μl culture medium.

Techniques: In Silico, Glycoproteomics, Recombinant

a Percentage cells expressing nucleocapsid protein relative to control for Apilimod and Camostat combinations. b Percentage cells expressing nucleocapsid protein for control, Apilimod (10 µM), Camostat (100 µM) or a combination of Apilimod (10 µM) and Camostat (100 µM). Data show the mean and standard error, from three independent experiments. *** indicates p < 0.001 by two-way ANOVA.

Journal: NPJ Digital Medicine

Article Title: Executable network of SARS-CoV-2-host interaction predicts drug combination treatments

doi: 10.1038/s41746-022-00561-5

Figure Lengend Snippet: a Percentage cells expressing nucleocapsid protein relative to control for Apilimod and Camostat combinations. b Percentage cells expressing nucleocapsid protein for control, Apilimod (10 µM), Camostat (100 µM) or a combination of Apilimod (10 µM) and Camostat (100 µM). Data show the mean and standard error, from three independent experiments. *** indicates p < 0.001 by two-way ANOVA.

Article Snippet: Caco-2 cells were pre-treated with Camostat Mesilate (ApexBio, B2082), Apilimod (Selleckchem, S6414), Miltefosine (Cayman Chemicals, 63280), Dexamethasone (EMD Millipore, 265005) or DMSO (Sigma) vehicle control at 2x the final concentration for 2 h prior to infection in 50 μl culture medium.

Techniques: Expressing, Control

Summary of predicted effective treatments for early and late severe COVID-19.

Journal: NPJ Digital Medicine

Article Title: Executable network of SARS-CoV-2-host interaction predicts drug combination treatments

doi: 10.1038/s41746-022-00561-5

Figure Lengend Snippet: Summary of predicted effective treatments for early and late severe COVID-19.

Article Snippet: Caco-2 cells were pre-treated with Camostat Mesilate (ApexBio, B2082), Apilimod (Selleckchem, S6414), Miltefosine (Cayman Chemicals, 63280), Dexamethasone (EMD Millipore, 265005) or DMSO (Sigma) vehicle control at 2x the final concentration for 2 h prior to infection in 50 μl culture medium.

Techniques: Recombinant